Smart watches, mHealth apps, and Bluetooth scales may just be edging into the social consciousness as a viable way to monitor personal health and manage chronic diseases, but EHR developers have been eyeing these technologies for some time, seeing them as valuable tools in the struggle to engage patients, prevent unnecessary readmissions, reduce costs, and promote long-term health.
Smart watches, mHealth apps, and Bluetooth scales may just be edging into the social consciousness as a viable way to monitor personal health and manage chronic diseases, but EHR developers have been eyeing these technologies for some time, seeing them as valuable tools in the struggle to engage patients, prevent unnecessary readmissions, reduce costs, and promote long-term health.
With Stage 2 of Meaningful Use bringing patient engagement to the forefront of providers’ minds, and a focus on accountable care making good outcomes profitable in a tangible way, healthcare organizations are making sure that they are equipped to guide their patients through the maze of quantifying and improving their own health.
As President of Population Health Management at Allscripts, Peter McClennen believes that a seamless, connected ecosystem of patient-centric technologies is the key to making an impact on healthcare delivery and the way patients interact with their providers. McClennen spoke to EHRintelligence about how wearable devices, mHealth apps, and patient portals will expand their role in the care continuum, allowing new methods of communication and more robust data for patients and providers alike.
Read the full story here: http://bit.ly/1wxyB7U
Source: EHR Intelligence
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More